"Innovations" (Developments to Watch, Mar. 24) incorrectly described a study on hearing that could begin next year. The study will examine a method for protecting inner-ear hair cells from damage due to a cancer drug.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.